Skip to content
Jazz Pharmaceuticals plc (JAZZ) Stock Price, Key Stats & Insider Trading
Home / Companies / JAZZ JAZ
Jazz Pharmaceuticals plc (JAZZ) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest JAZZ Insider Trades
About Jazz Pharmaceuticals plc (JAZZ) Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Headquarters DUBLIN
Employees 2,890
Listed 2007
Exchange XNAS https://www.jazzpharmaceuticals.com SEC filings for JAZZ on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 7 28,456 $6.82M Grant or award 11 17,655 Option exercise 4 20,644
JAZZ Insider Transactions (Form 4) 75 90 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Mar 5, 2026 BC Bruce C. Cozadd - Director Tax withholding / forfeiture Ordinary Shares
Recent JAZZ Form 8-K Filings 5
Recent JAZZ Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 27, 2026 ROBERT IANNONE Officer 76,921 $19.21M View on EDGAR Aug 7, 2026 ORiordan Anne Director
JAZZ Insider Trading - FAQ
What is the latest insider trade for JAZZ? Jazz Pharmaceuticals plc (JAZZ) had 26 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for JAZZ runs to 90 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying JAZZ stock? No insider purchases of JAZZ were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling JAZZ stock? 7 insider sales of JAZZ were filed in the last 90 days, totaling $6.82M.
Where can I see JAZZ SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks JAZZ Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow JAZZ insider buys? Create a free InsiderAlpha account and press Watch on this page to add JAZZ to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track JAZZ insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Jul 1, 2026
Market cap $15.87B
P/E ratio -
Dividend yield -
Average volume 926.4K
52 week high $266.38
52 week low $123.88
Today's high $250.64
Today's low $244.49
Open $249.48
Volume 1.21M
Previous close $251.10
Shares outstanding 64.91M Market cap
$15.87B
2,890 employees
JAZZ Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 7 sales totaling $6.82M.
Most-Active JAZZ Insiders - Last 90 Days 10 Tax withholding / forfeiture 6 17,927
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Mar 5, 2026 PJ Philip L. Johnson - Officer Tax withholding / forfeiture Ordinary Shares 2,615 $188.69 $493K
Mar 5, 2026 SP Samantha Pearce - Officer Tax withholding / forfeiture Ordinary Shares 2,503 $188.69 $472K
Mar 5, 2026 RI Robert Iannone - Officer Tax withholding / forfeiture Ordinary Shares 6,209 $188.69 $1.17M
Mar 9, 2026 PC Patricia Carr - Officer Open-market sale Ordinary Shares 1,287 $182.94 $235K
Mar 5, 2026 PC Patricia Carr - Officer Tax withholding / forfeiture Ordinary Shares 1,436 $186.77 $268K
Mar 5, 2026 RG Renee D. Gala - Officer Tax withholding / forfeiture Ordinary Shares 7,065 $188.69 $1.33M
Mar 5, 2026 NP Neena M. Patil - Officer Tax withholding / forfeiture Ordinary Shares 5,000 $188.69 $943K
Mar 3, 2026 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 3,159 $186.09 $588K
Mar 3, 2026 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 2,608 $186.73 $487K
Mar 3, 2026 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 233 $187.84 $44K
Feb 27, 2026 NR Norbert G. Riedel - Director Option exercise Ordinary Shares 3,415 $138.08 $472K
Feb 27, 2026 NR Norbert G. Riedel - Director Open-market sale Ordinary Shares 3,415 $192.00 $656K
Feb 27, 2026 NR Norbert G. Riedel - Director Option exercise Non-Qualified Stock Option (right to buy) 3,415 $0.00 -
Feb 26, 2026 SP Samantha Pearce - Officer Grant or award Ordinary Shares 9,782 $0.00 -
Feb 26, 2026 RI Robert Iannone - Officer Grant or award Ordinary Shares 14,822 $0.00 -
Feb 27, 2026 PC Patricia Carr - Officer Open-market sale Ordinary Shares 1,117 $190.91 $213K
Feb 26, 2026 PC Patricia Carr - Officer Grant or award Ordinary Shares 2,223 $0.00 -
Feb 26, 2026 PC Patricia Carr - Officer Open-market sale Ordinary Shares 1,253 $194.11 $243K
Feb 26, 2026 RG Renee D. Gala - Officer Grant or award Ordinary Shares 44,465 $0.00 -
Feb 26, 2026 TL Ted W. Love - Director Grant or award Ordinary Shares 1,527 $0.00 -
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Ordinary Shares 20,125 $113.10 $2.28M
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Ordinary Shares 875 $113.10 $99K
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Ordinary Shares 27,084 $137.12 $3.71M
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Ordinary Shares 2,916 $137.12 $400K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 16,602 $192.53 $3.20M
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 875 $192.07 $168K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 15,555 $190.28 $2.96M
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 2,916 $189.81 $553K
Feb 26, 2026 NP Neena M. Patil - Officer Grant or award Ordinary Shares 10,079 $0.00 -
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 11,529 $191.65 $2.21M
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 3,523 $193.58 $682K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 1,061 $190.00 $202K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 549 $190.80 $105K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 1,784 $191.88 $342K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 1,009 $192.79 $195K
Feb 26, 2026 NP Neena M. Patil - Officer Open-market sale Ordinary Shares 197 $193.60 $38K
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Incentive Stock Option (right to buy) 875 $0.00 -
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Incentive Stock Option (right to buy) 2,916 $0.00 -
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Non-Qualified Stock Option (right to buy) 20,125 $0.00 -
Feb 26, 2026 NP Neena M. Patil - Officer Option exercise Non-Qualified Stock Option (right to buy) 27,084 $0.00 -
Jan 16, 2026 PC Patricia Carr - Officer Grant or award Ordinary Shares 2,370 $0.00 -
Jan 16, 2026 NP Neena M. Patil - Officer Grant or award Ordinary Shares 8,852 $0.00 -
Jan 16, 2026 NP Neena M. Patil - Officer Derivative Ordinary Shares 3,275 $171.16 $561K
Jan 16, 2026 SP Samantha Pearce - Officer Grant or award Ordinary Shares 3,637 $0.00 -
Jan 16, 2026 SP Samantha Pearce - Officer Tax withholding / forfeiture Ordinary Shares 1,599 $171.16 $274K
Jan 16, 2026 RI Robert Iannone - Officer Tax withholding / forfeiture Ordinary Shares 4,140 $171.16 $709K
Jan 16, 2026 RI Robert Iannone - Officer Grant or award Ordinary Shares 11,699 $0.00 -
Jan 16, 2026 RG Renee D. Gala - Officer Grant or award Ordinary Shares 12,741 $0.00 -
Jan 16, 2026 RG Renee D. Gala - Officer Tax withholding / forfeiture Ordinary Shares 5,371 $171.16 $919K
Jan 16, 2026 BC Bruce C. Cozadd - Director Grant or award Ordinary Shares 35,917 $0.00 -
Jan 16, 2026 BC Bruce C. Cozadd - Director Tax withholding / forfeiture Ordinary Shares 17,453 $171.16 $2.99M
Dec 2, 2025 KO Kenneth W. O'Keefe - Director Tax withholding / forfeiture Ordinary Shares 603 $173.07 $104K
Nov 26, 2025 BC Bruce C. Cozadd - Director Option exercise Ordinary Shares 76,689 $123.36 $9.46M
Nov 26, 2025 BC Bruce C. Cozadd - Director Option exercise Ordinary Shares 811 $123.36 $100K
Nov 26, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 30,487 $178.06 $5.43M
Nov 26, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 8,380 $179.23 $1.50M
Nov 26, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 507 $179.79 $91K
Nov 26, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 38,126 $177.27 $6.76M
Nov 26, 2025 BC Bruce C. Cozadd - Director Option exercise Incentive Stock Option (right to buy) 811 $0.00 -
Nov 26, 2025 BC Bruce C. Cozadd - Director Option exercise Non-Qualified Stock Option (right to buy) 76,689 $0.00 -
Nov 20, 2025 HM Heather Ann McSharry - Director Option exercise Non-Qualified Stock Option (right to buy) 3,415 $0.00 -
Nov 18, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 717 $182.60 $131K
Nov 20, 2025 BC Bruce C. Cozadd - Director Grant or award Ordinary Shares 2,506 $0.00 -
Nov 18, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 3,384 $180.09 $609K
Nov 18, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 8,382 $180.88 $1.52M
Nov 18, 2025 BC Bruce C. Cozadd - Director Open-market sale Ordinary Shares 5,517 $181.81 $1.00M
$ELAN
Elanco Animal Health Inc
Bruce C. Cozadd - DirectorOpen-market sale$1.52M
